Overview of Dr. Bomback
Dr. Andrew Bomback is a nephrologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Allen Hospital. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 14 years. Dr. Bomback accepts several types of health insurance, listed below. He is one of 171 doctors at New York-Presbyterian Hospital and one of 62 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Nephrology. He has more than 100 publications and over 500 citings.
Office
622 W 168th St
Ph 4-124
New York, NY 10032
Education & Training
- University of North Carolina HospitalsResidency, Internal Medicine, 2004 - 2008
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2003
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2009 - 2026
- NJ State Medical License 2022 - 2025
- CT State Medical License 2022 - 2023
- NC State Medical License 2004 - 2009
- American Board of Internal Medicine Nephrology
Clinical Trials
- Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy Start of enrollment: 2009 Feb 01
- Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Start of enrollment: 2008 Dec 01
- MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 50 citationsDrug-induced glomerular disease: direct cellular injury.Glen S. Markowitz, Andrew S. Bomback, Mark A. Perazella
Clinical Journal of the American Society of Nephrology. 2015-07-07 - 91 citationsA Simple Algorithm to Predict Incident Kidney DiseaseAbhijit V. Kshirsagar, Heejung Bang, Andrew S. Bomback, Suma Vupputuri, David A. Shoham
Archives of Internal Medicine. 2008-12-08 - 29 citationsGestational Diabetes Mellitus Alone in the Absence of Subsequent Diabetes Is Associated With Microalbuminuria: Results from the Kidney Early Evaluation Program (KEEP)Andrew S. Bomback, Yelena Rekhtman, Adam Whaley-Connell, Abhijit V. Kshirsagar, James R. Sowers
Diabetes Care. 2010-12-01
Other
- Diagnosis and classification of renal disease in systemic lupus erythematosusBomback AS, Appel GB
http://www.uptodate.com/contents/diagnosis-and-classification-of-renal-disease-in-systemic-lupus-ery
UpToDate, Wolters Kluwer Health - 2013-02-28 - End-stage renal disease due to lupus nephritisBomback AS, Appel GB
http://www.uptodate.com/contents/end-stage-renal-disease-due-to-lupus-nephritis
UpToDate, Wolters Kluwer Health - 2013-04-12
Press Mentions
- Novartis Oral Fabhalta® (Iptacopan) Sustained Clinically Meaningful Results at One Year in Phase III C3 Glomerulopathy (C3G) TrialOctober 26th, 2024
- The Sentence That Broke MeApril 29th, 2020
- The Stethoscope Has Much to Teach, if We Just ListenAugust 16th, 2017
- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Florida BlueSelect
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Wyoming BlueChoice Personal
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
Empire BCBS HMOEmpire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: